Chromosomal and oxidative DNA damage in non-functioning pituitary adenomas

Bitgen N., Bayram F., Hamurcu Z., Ozturk F., Simsek Y., Baskol G., ...Daha Fazla

ENDOKRYNOLOGIA POLSKA, sa.2, ss.97-103, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5603/ep.a2020.0084
  • Dergi Adı: ENDOKRYNOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.97-103
  • Anahtar Kelimeler: 8-OHdG levels, DNA damage, micronucleus, non-functioning pituitary adenoma, INCREASED MICRONUCLEUS, LYMPHOCYTES, GENOTOXICITY, PREVALENCE, MANAGEMENT, FREQUENCY, 8-OHDG, CANCER, TUMORS
  • Erciyes Üniversitesi Adresli: Evet

Özet

Introduction: Clinically non-functioning pituitary adenomas (NFPA) are common tumours of the pituitary gland and are mainly considered as benign. The primary aim of this study was to research the effects of NFPA on genome instability in patients with non-functioning pituitary adenoma by using the cytokinesis-block micronucleus cytome (CBMN-cyt) assay and 8-hydroxy-2'-deoxyguanosine (8-OHdG) assay. The second objective of this study was to assess whether there is a relationship between age, pituitary adenoma diameters, 8-OHdG levels, CBMN site assay parameters, and tumour aggressiveness. Material and methods: The study was performed on 30 patients who had been diagnosed with NFPA and were admitted to the Department of Endocrinology and Metabolism, and 20 healthy subjects of similar age and sex. Results: Micronucleus (MN), nucleoplasmic bridges (NPBs), nuclear bud (NBUD) frequencies, and apoptotic and necrotic cell frequencies in patients with NFPA were found to be significantly higher than in control subjects, and plasma 8-OHdG levels in patients with NFPA were statistically significantly lower than control subjects in this study. Conclusions: It is believed that this is the first study to evaluate the aggressiveness of tumour with chromosome/oxidative DNA damage in patients with NFPA. However, further studies are needed in order to understand the cause of NFPA aggression and to evaluate these patients in terms of risk of cancer.